Cargando…
Immunopathology of RSV: An Updated Review
RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding of virus–host interactions and immunity contribute to the lack of biological countermeasures. This review updates the curre...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703574/ https://www.ncbi.nlm.nih.gov/pubmed/34960746 http://dx.doi.org/10.3390/v13122478 |
_version_ | 1784621496557109248 |
---|---|
author | Bergeron, Harrison C. Tripp, Ralph A. |
author_facet | Bergeron, Harrison C. Tripp, Ralph A. |
author_sort | Bergeron, Harrison C. |
collection | PubMed |
description | RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding of virus–host interactions and immunity contribute to the lack of biological countermeasures. This review updates the current understanding of RSV immunity and immunopathology with a focus on interferon responses, animal modeling, and correlates of protection. |
format | Online Article Text |
id | pubmed-8703574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87035742021-12-25 Immunopathology of RSV: An Updated Review Bergeron, Harrison C. Tripp, Ralph A. Viruses Review RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding of virus–host interactions and immunity contribute to the lack of biological countermeasures. This review updates the current understanding of RSV immunity and immunopathology with a focus on interferon responses, animal modeling, and correlates of protection. MDPI 2021-12-10 /pmc/articles/PMC8703574/ /pubmed/34960746 http://dx.doi.org/10.3390/v13122478 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Bergeron, Harrison C. Tripp, Ralph A. Immunopathology of RSV: An Updated Review |
title | Immunopathology of RSV: An Updated Review |
title_full | Immunopathology of RSV: An Updated Review |
title_fullStr | Immunopathology of RSV: An Updated Review |
title_full_unstemmed | Immunopathology of RSV: An Updated Review |
title_short | Immunopathology of RSV: An Updated Review |
title_sort | immunopathology of rsv: an updated review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703574/ https://www.ncbi.nlm.nih.gov/pubmed/34960746 http://dx.doi.org/10.3390/v13122478 |
work_keys_str_mv | AT bergeronharrisonc immunopathologyofrsvanupdatedreview AT trippralpha immunopathologyofrsvanupdatedreview |